Amp 20logo 205.2019

Amplified Sciences, Inc.

Clinical stage diagnostics company leveraging composition of matter IP with lead assay in pancreatic cancer and 6 months from CLIA regulatory milestone

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location West Lafayette, IN, USA
  • Currency USD
  • Founded March 2016
  • Employees 4
  • Incorporation Type C-corp
  • Website amplifiedsciences.com

Company Summary

Clinical stage life science in-vitro diagnostics company focused on accurately detecting debilitating diseases sooner with a lead assay for early detection of pancreatic cancer supported by clinical published data. Open $3M Seed round ($1.5M soft circled with 2 VC co-leads) funds opening of clinical lab, CLIA regulatory milestone, commercial launch in 2023, and scales additional assays on their proprietary ultrasensitive chemistry platform.